Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIVAROXABAN Cause Musculoskeletal stiffness? 152 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 152 reports of Musculoskeletal stiffness have been filed in association with RIVAROXABAN (Rivaroxaban). This represents 0.1% of all adverse event reports for RIVAROXABAN.

152
Reports of Musculoskeletal stiffness with RIVAROXABAN
0.1%
of all RIVAROXABAN reports
3
Deaths
34
Hospitalizations

How Dangerous Is Musculoskeletal stiffness From RIVAROXABAN?

Of the 152 reports, 3 (2.0%) resulted in death, 34 (22.4%) required hospitalization, and 9 (5.9%) were considered life-threatening.

Is Musculoskeletal stiffness Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIVAROXABAN. However, 152 reports have been filed with the FAERS database.

What Other Side Effects Does RIVAROXABAN Cause?

Gastrointestinal haemorrhage (20,041) Haemorrhage (6,571) Epistaxis (5,629) Rectal haemorrhage (4,501) Off label use (4,463) Haematuria (4,387) Upper gastrointestinal haemorrhage (4,247) Cerebrovascular accident (4,111) Anaemia (3,907) Acute kidney injury (3,735)

What Other Drugs Cause Musculoskeletal stiffness?

ADALIMUMAB (10,762) METHOTREXATE (9,903) ETANERCEPT (9,744) TOFACITINIB (7,354) TOCILIZUMAB (6,346) RITUXIMAB (6,058) LEFLUNOMIDE (6,031) ABATACEPT (5,926) SECUKINUMAB (5,655) HYDROXYCHLOROQUINE (5,271)

Which RIVAROXABAN Alternatives Have Lower Musculoskeletal stiffness Risk?

RIVAROXABAN vs RIVASTIGMINE RIVAROXABAN vs RIVOTRIL RIVAROXABAN vs RIZATRIPTAN RIVAROXABAN vs ROACTEMRA RIVAROXABAN vs ROCURONIUM

Related Pages

RIVAROXABAN Full Profile All Musculoskeletal stiffness Reports All Drugs Causing Musculoskeletal stiffness RIVAROXABAN Demographics